Skip to Main Content

Paper Details

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML.
Blood Adv
13
2021
Author NameAffiliation
Jean-Baptiste MicolGustave Roussy Institute
Emmanuelle ClappierSaint-Louis University Hospital
Emmanuel RaffouxSaint-Louis University Hospital
Claude PreudhommeCentre Hospitalier Universitaire (CHU) Lille, INSERM UMR-S 7
Herv?? DombretSaint-Louis University Hospital
  • 1 - 5

Datasets

Release 1.2